About DNA and RNA Extraction Kit
DNA and RNA extraction is a combination of chemical and physical processes involved in the isolation of DNA or RNA. Extraction by chemical method involves the utilization of extraction kits for detection and extraction of DNA/RNA from the sample. DNA and RNA extraction kits simplify the process of extraction by eliminating the need for mechanical disruption and by decreasing hands-on time. Moreover, enhanced protocols for specific samples deliver reproducible purification of high-quality DNA/RNA.
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Unit | Value (USD Million) |
The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global DNA and RNA Extraction Kit market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Thermo Fisher Scientific (United States), Promega (United States), Primerdesign (United Kingdom), Bioneer Corporation (United States), PCR Biosystems (United Kingdom), BioFire Defense (United States), Qiagen (Germany), Bio-Rad Laboratories (United States), Akonni Biosystems, Inc. (United States), Roche Life Science (Germany), Agilent Technologies, Inc. (United States), Illumina, Inc. (United States), PerkinElmer Inc. (United States), Merck KGaA (Germany) and LGC Biosearch Technologies (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Analytik Jena GmbH (Germany) and AutoGen, Inc. (United States).
Segmentation Overview
AMA Research has segmented the market of Global DNA and RNA Extraction Kit market by Type (DNA Extraction Kits {Tissue, Blood, Cell, Plant, Forensic, Viral, Bacterial, Buccal, and Cell-free} and RNA Extraction Kits {Blood, Cultured Cells, FFPE, Plant, Tissue, Yeast, Bacteria, and Viral}), Application (Diagnostics, Drug Discovery & Development, Personalized Medicine, Agriculture & Animal Research and Others) and Region.
On the basis of geography, the market of DNA and RNA Extraction Kit has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User, the sub-segment i.e. Hospitals & Diagnostic Centers will boost the DNA and RNA Extraction Kit market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Rise in Government Funding by Developing Countries
Market Growth Drivers:
Increased Automation in DNA/RNA Extraction Technology and Increase in Demand for User-Friendly Products
Challenges:
Lack of Awareness and Low Levels of Product Penetration in Undeveloped Markets
Restraints:
High-Cost Associated with DNA and RNA Extraction Kit
Opportunities:
Growth in Funding for Research and Development of Extraction Kits, and Advancement in Technology and Improving Regulatory and Reimbursement Scenario
Market Leaders and their expansionary development strategies
On 17th March 2020, QIAGEN has announced plans to dramatically ramp up the global production capacity of RNA extraction kits that are used as part of workflows around the world to detect nucleic acid from SARS-CoV-2, the novel coronavirus that causes COVID-19.
On 24th March 2020, Bruker Corporation has announced a distribution agreement with Primer Design Ltd (UK), a subsidiary of Novacyt SA, for Bruker-Hain Diagnostics to distribute the CE-IVD-labeled genesig real-time PCR coronavirus (COVID-2019) assay, effective immediately. Bruker-Hain Diagnostics has a portfolio of DNA/RNA extraction and preparation systems and kits.
Key Target Audience
DNA and RNA Extraction Kit Manufacturers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.